Premium Only Content
Excess mortality in England post COVID-19 pandemic: implications for secondary prevention
Excess mortality in England post COVID-19 pandemic: implications for secondary prevention
Many countries, including the UK, have continued to experience an apparent excess of deaths long after the peaks associated with the COVID-19 pandemic in 2020 and 2021.
Numbers of excess deaths estimated in this period are considerable.
The UK Office for National Statistics (ONS) has calculated that there were 7.2% or 44,255 more deaths registered in the UK in 2022
OECD, UK
https://stats.oecd.org/index.aspx?que...
Excess deaths in 2022, 52,514 (9.26%)
This persisted into 2023 with 8.6% or 28,024 more deaths registered in the first six months of the year than expected.
OECD, UK, weeks 1 – 44, 2023
Excess deaths, 49,389 (9.44%)
The causes of these excess deaths are likely to be multiple and could include the direct effects of Covid-19 infection,
acute pressures on NHS acute services resulting in poorer outcomes from episodes of acute illness,
and disruption to chronic disease detection and management.
Further analysis by cause and by age- and sex-group may help quantify the relative contributions of these causes.
Office for Health Improvement and Disparities
3rd June 2022 to 30th June 2023
Excess deaths for all causes were relatively greatest for 50–64 year olds (15% higher than expected)
11% higher for 25–49 and under 25 year olds,
and about 9% higher for over 65s
Several causes
3rd June 2022–30th June 2023
All cardiovascular diseases, 12%
Heart failure, 20%
Ischaemic heart disease, 15
Liver diseases, 19%
Acute respiratory infections, 14%
Diabetes, 13%
For middle-aged adults (50–64)
Cardiovascular diseases, 33% higher than expected
Ischaemic heart disease, 44%
Cerebrovascular disease, 40%
Heart failure 39% higher
Deaths involving acute respiratory infections, 43% higher
Diabetes, deaths were 35% higher
The pattern now is one of persisting excess deaths which are most prominent in relative terms in middle-aged and younger adults
Timely and granular analyses are needed to describe such trends and so to inform prevention and disease management efforts.
JP-S is Partner at Lane Clark & Peacock LLP, Chair of the Royal Society for Public Health and reports personal fees from Novo Nordisk and Pfizer Ltd outside of this submitted work.
Many countries, including the UK, have continued to experience an apparent excess of deaths long after the peaks associated with the COVID-19 pandemic in 2020 and 2021.
Numbers of excess deaths estimated in this period are considerable.
The UK Office for National Statistics (ONS) has calculated that there were 7.2% or 44,255 more deaths registered in the UK in 2022
OECD, UK
https://stats.oecd.org/index.aspx?que...
Excess deaths in 2022, 52,514 (9.26%)
This persisted into 2023 with 8.6% or 28,024 more deaths registered in the first six months of the year than expected.
OECD, UK, weeks 1 – 44, 2023
Excess deaths, 49,389 (9.44%)
The causes of these excess deaths are likely to be multiple and could include the direct effects of Covid-19 infection,
acute pressures on NHS acute services resulting in poorer outcomes from episodes of acute illness,
and disruption to chronic disease detection and management.
Further analysis by cause and by age- and sex-group may help quantify the relative contributions of these causes.
Office for Health Improvement and Disparities
3rd June 2022 to 30th June 2023
Excess deaths for all causes were relatively greatest for 50–64 year olds (15% higher than expected)
11% higher for 25–49 and under 25 year olds,
and about 9% higher for over 65s
Several causes
3rd June 2022–30th June 2023
All cardiovascular diseases, 12%
Heart failure, 20%
Ischaemic heart disease, 15
Liver diseases, 19%
Acute respiratory infections, 14%
Diabetes, 13%
For middle-aged adults (50–64)
Cardiovascular diseases, 33% higher than expected
Ischaemic heart disease, 44%
Cerebrovascular disease, 40%
Heart failure 39% higher
Deaths involving acute respiratory infections, 43% higher
Diabetes, deaths were 35% higher
The pattern now is one of persisting excess deaths which are most prominent in relative terms in middle-aged and younger adults
Timely and granular analyses are needed to describe such trends and so to inform prevention and disease management efforts.
JP-S is Partner at Lane Clark & Peacock LLP, Chair of the Royal Society for Public Health and reports personal fees from Novo Nordisk and Pfizer Ltd outside of this submitted work.
-
10:34
justintech
18 hours ago $7.08 earnedBest Gaming PC Under $1000! - In 2024
24K4 -
9:34
Dr David Jockers
15 hours ago $5.69 earnedThe Shocking Truth About Butter
63.1K2 -
9:05
Bearing
22 hours agoJaguar's Woke New Ad is SHOCKINGLY Bad 😬
13.1K62 -
7:55
Chris From The 740
14 hours ago $5.09 earnedWill The AK Project Function - Let's Head To The Range And Find Out
9.86K7 -
2:39
BIG NEM
10 hours agoHygiene HORROR: The "Yurt Incident"
6.2K1 -
3:19:21
Price of Reason
14 hours agoHollywood Celebrities FLEE the US After Trump Win! Wicked Movie Review! Gaming Journos MAD at Elon!
74K50 -
3:55:45
Alex Zedra
9 hours agoLIVE! Last Map on The Escape: SCARY GAME.
72.2K3 -
1:14:07
Glenn Greenwald
14 hours agoComedian Dave Smith On Trump's Picks, Israel, Ukraine, and More | SYSTEM UPDATE #370
170K229 -
1:09:07
Donald Trump Jr.
16 hours agoBreaking News on Latest Cabinet Picks, Plus Behind the Scenes at SpaceX & Darren Beattie Joins | TRIGGERED Ep.193
208K718 -
1:42:43
Roseanne Barr
12 hours ago $62.84 earnedGod Won, F*ck You | The Roseanne Barr Podcast #75
92.5K198